A Phase 2, Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Crossover Study Of The Efficacy Of Fesoterodine In Increasing Urethral Pressure In Stress Urinary Incontinence Patients.

Trial Profile

A Phase 2, Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Crossover Study Of The Efficacy Of Fesoterodine In Increasing Urethral Pressure In Stress Urinary Incontinence Patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2014

At a glance

  • Drugs Fesoterodine (Primary)
  • Indications Stress incontinence
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 02 Sep 2011 Results presented at the 41st Annual Meeting of the International Continence Society.
    • 10 Aug 2010 Additional location [Denmark] identified as reported by ClinicalTrials.gov.
    • 10 Aug 2010 Actual end date (July 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top